You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Shining a light in the black box of orphan drug pricing
|
|---|---|
| Published in |
Orphanet Journal of Rare Diseases, April 2014
|
| DOI | 10.1186/1750-1172-9-62 |
| Pubmed ID | |
| Authors |
Eline Picavet, Thomas Morel, David Cassiman, Steven Simoens |
| Abstract |
The pricing mechanism of orphan drugs appears arbitrary and has been referred to as a "black box". Therefore, the aim of this study is to investigate how drug- and disease-specific variables relate to orphan drug prices. Additionally, we aim to explore if certain country-specific pricing and reimbursement policies affect the price level of orphan drugs. |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 3 | 23% |
| United States | 2 | 15% |
| Spain | 2 | 15% |
| Unknown | 6 | 46% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 77% |
| Scientists | 3 | 23% |
Mendeley readers
The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Nepal | 1 | <1% |
| United States | 1 | <1% |
| Ireland | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 125 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 22 | 17% |
| Researcher | 21 | 16% |
| Other | 15 | 12% |
| Student > Bachelor | 11 | 9% |
| Student > Ph. D. Student | 11 | 9% |
| Other | 27 | 21% |
| Unknown | 22 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 35 | 27% |
| Pharmacology, Toxicology and Pharmaceutical Science | 18 | 14% |
| Economics, Econometrics and Finance | 10 | 8% |
| Social Sciences | 9 | 7% |
| Agricultural and Biological Sciences | 7 | 5% |
| Other | 23 | 18% |
| Unknown | 27 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2015.
All research outputs
#3,188,557
of 25,374,647 outputs
Outputs from Orphanet Journal of Rare Diseases
#440
of 3,105 outputs
Outputs of similar age
#30,819
of 241,070 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#6
of 45 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,105 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 241,070 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.